Type 2 Treatment Algorithm

1. Creatinine > =1.4 (Renally impaired) Rx insulin OR diet AND avoid biguanides or SASKA's, Begin Insulin

2. Creatinine < 1.4 (Intact renal function)

   1. BMI >=30 (Obese) BEGIN GLP-1 therapy

      1. A1c <8% CONTINUE GLP-1 if tolerated 

      2. A1c >=8% ADD SGLT-2  if c-peptide > 2.5 OR Precose 

         1. A1c < 8% CONTINUE if tolerated

         2. A1c >=8% ADD BASAL insulin

   2. BMI < 30 BEGIN with Diet Therapy

      1. A1c <8% then CONTINUE diet

      2. A1c >=8% ADD DPP-4

         1. A1c < 8% CONTINUE DPP-4 if tolerated 

         2. A1c >=8% ADD SGLT-2  if c-peptide > 2.5 OR Precose OR STOP oral Rx and BEGIN insulin

Home->Type 2 Area Menu->Type 2 Rx Algorithm

Type 2 Area Menu

Home

The NDC considers the following Rx algorithm published by the ACP as somewhat harmful and misguided due to its recommendation of (1) KATP- channel antagonists which cause coronary vasoconstriction (sulfonylureas) as first line therapy (2) A1c action points of >7% which in the absence of any corroberating data appear overly tight and may lead to excessive hypoglycemia, morbidity, and mortality and (3) triple therapy which has no long-term safety data to recommend it:-

Home->Type 2 Area Menu->Type 2 Rx Algorithm Type 2 Area Menu Home